Related Experiment Video
Updated: Jun 27, 2025

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis
Kaarina Kowalec1,2, Arvid Harder2, Casandra Dolovich3
1Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Objective:
Comorbid anxiety occurs often in MS and is associated with disability progression. Polygenic scores offer a possible means of anxiety risk prediction but often have not been validated outside the original discovery population. We aimed to investigate the association between the Generalized Anxiety Disorder 2-item scale polygenic score with anxiety in MS.
Methods:
Using a case-control design, participants from Canadian, UK Biobank, and United States cohorts were grouped into cases (MS/comorbid anxiety) or controls (MS/no anxiety, anxiety/no immune disease or healthy). We used multiple anxiety measures: current symptoms, lifetime interview-diagnosed, and lifetime self-report physician-diagnosed. The polygenic score was computed for current anxiety symptoms using summary statistics from a previous genome-wide association study and was tested using regression.
Results:
A total of 71,343 individuals of European genetic ancestry were used: Canada (n = 334; 212 MS), UK Biobank (n = 70,431; 1,390 MS), and the USA (n = 578 MS). Meta-analyses identified that in MS, each 1-SD increase in the polygenic score was associated with ~50% increased odds of comorbid moderate anxious symptoms compared to those with less than moderate anxious symptoms (OR: 1.47, 95% CI: 1.09-1.99). We found a similar direction of effects in the other measures. MS had a similar anxiety genetic burden compared to people with anxiety as the index disease.
Interpretation:
Higher genetic burden for anxiety was associated with significantly increased odds of moderate anxious symptoms in MS of European genetic ancestry which did not differ from those with anxiety and no comorbid immune disease. This study suggests a genetic basis for anxiety in MS.
Insights
Higher genetic risk for anxiety is linked to increased anxiety symptoms in Multiple Sclerosis (MS). This suggests a genetic basis for anxiety in MS patients, impacting disease progression.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- Comorbid anxiety is prevalent in Multiple Sclerosis (MS) and linked to disability progression.
- Polygenic scores (PS) can predict anxiety risk but require validation in diverse populations.
- Investigating the Generalized Anxiety Disorder 2-item scale PS in MS is crucial for understanding anxiety etiology.
Purpose of the Study:
- To assess the association between the Generalized Anxiety Disorder 2-item scale polygenic score and anxiety in individuals with MS.
- To determine if genetic predisposition for anxiety is a significant factor in the development of anxiety in MS patients.
Main Methods:
- A case-control study design was employed, including participants from Canadian, UK Biobank, and United States cohorts.
- Individuals were categorized into cases (MS with comorbid anxiety) and controls (MS without anxiety, or anxiety without immune disease, or healthy controls).
- Anxiety was measured using current symptoms, lifetime interview diagnosis, and lifetime self-report physician diagnosis; the PS was computed for current anxiety symptoms.
Main Results:
- The study analyzed 71,343 individuals of European genetic ancestry.
- A 1-SD increase in the polygenic score was associated with approximately 50% increased odds of moderate anxious symptoms in MS patients (OR: 1.47, 95% CI: 1.09-1.99).
- Similar trends were observed across different anxiety measures, indicating a comparable genetic burden for anxiety in MS as in individuals with anxiety as the primary condition.
Conclusions:
- Elevated genetic predisposition for anxiety is significantly associated with increased odds of moderate anxiety symptoms in individuals with MS.
- The genetic burden for anxiety in MS is comparable to that in individuals with anxiety and no comorbid immune disease.
- These findings suggest a notable genetic component underlying anxiety in Multiple Sclerosis.
Related Concept Videos
Generalized Anxiety Disorder
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Social Anxiety Disorder
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Panic Disorder
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...

